FiercePharma
Media & Internet · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
685 3rd Ave Fl 21, New York City, New Yo...Website
www.fiercepharma.comRevenue
$11.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About FiercePharma
FiercePharma is a digital media publication, reporting and delivering daily news and objective analysis for business professionals in global industries. FiercePharma offers broad coverage serving a wide range of specific functional interests, including manufacturing regulation, financial management, quality control and production methods; shareholder pressure and speed-to-market strategies; sales and marketing access to physicians and navigating payer rules; the impact of pricing and partnerships on the pipeline; and the influence of big data, executive moves and social media on it all.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is FiercePharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if FiercePharma is spiking on competitors!
Check if FiercePharma has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at FiercePharma
Funding: Get notified immidiatlly once FiercePharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when FiercePharma launches new products
Click to see if FiercePharma had a recent Job posting/layoffs
Earning: See what the market has to say on FiercePharma recently announced quarterly report
FiercePharma, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined FiercePharma as Masked Content
Find 2 more new buyers
Compare Similar Companies to FiercePharma
Compare insights from companies similar to FiercePharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
FiercePharma
$11.2M
11-50
Private
-
2008
N/A
Company Profile Activity
Activity Insights
FiercePharma is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
FiercePharma is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about FiercePharma.
FiercePharma Tech Stack
A closer look at the technologies used by FiercePharma
FiercePharma News & Media
Axsome fends off generic competition to narcolepsy med Sunosi until 2040 | Fierce Pharma
With a new patent settlement, Axsome Therapeutics can lower its sword against prospective generics makers taking aim at its narcolepsy med Sunosi. | The company inked another settlement with a prospective generic maker, leaving no further pending patent litigation for its Sunosi on the table.AbbVie plots 85 summer layoffs tied to Allergan aesthetics unit in California | Fierce Pharma
A year after a major layoff round at its Allergan headquarters in California, AbbVie is making more edits to its workforce with a new round of 85 layoffs. | The layoffs at AbbVie's Irvine, California, location will take effect on July 20, according to a recent WARN notice.Novartis, AbbVie plan summer layoffs on opposite coasts - Fierce Pharma
Two Big Pharmas are shrinking their U.S. | AbbVie's 85 layoffs are tied to its Allergan Aesthetics headquarters in California, while Novartis is cutting more staff at its U.S. HQ in New Jersey.BMS-Hengrui, Takeda layoffs, Daiichi—Fierce Pharma Asia
Bristol Myers Squibb and Hengrui Pharma signed a massive deal worth up to $15.2 billion. Takeda aims to cut 4,500 jobs in fiscal year 2026. | BMS and Hengrui signed a massive deal worth up to $15.2 billion. Takeda aims to cut 4,500 jobs in fiscal 2026. Daiichi Sankyo aims to be a global top-5 oncology player while expanding beyond antibody-drug conjugates. Plus more.
Read more news
Top Media & Internet Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding FiercePharma
Sign Up For FreeTo access detailed company insights
FiercePharma is a digital media publication, reporting and delivering daily news and objective analysis for business professionals in global industries. FiercePharma offers broad coverage serving a wide range of specific functional interests, including manufacturing regulation, financial management, quality control and production methods; sharehold... Read More
